This study examined the role of the actin cytoskeleton in Rho-kinase-mediated
INTRODUCTION
A network of resistance arteries controls the distribution of blood flow through the cerebral circulation. Arterial tone is determined by smooth muscle contractility and is regulated by a number of physiological factors, including metabolic state (9) , humoral and neural stimuli (27) , intraluminal pressure (10; 17) , as well as endothelial factors (16) .
Many of these stimuli initiate changes in vascular tone via G-protein coupled receptors and the activation of downstream signaling pathways. Effector proteins within such transduction pathways can influence vascular smooth muscle contractility by altering the Ca 2+ sensitivity of the myofilaments (29) and/or the activity of ion channels that control membrane potential and voltage-gated Ca 2+ entry (22) .
The Rho pathway is a primary signaling pathway regulating vascular smooth muscle contraction. Rho signaling is initiated via receptors coupled to G 12/13 , resulting in the activation of the small GTPase RhoA and its principal downstream effector, Rhokinase (3; 28). Rho-kinase directly phosphorylates and inactivates myosin light chain phosphatase (MLCP), ultimately increasing the phosphorylation state of myosin and facilitating contraction (30) . Recent studies suggest that Rho-kinase is also capable of modulating ion channels and membrane potential (8; 19) . In particular, we found that Rho-kinase was essential to the depolarization and constriction of cerebral arteries in response to agonists such as uridine triphosphate (UTP). Electrophysiological measurements revealed that depolarization involved the Rho-mediated inhibition of a delayed rectifying K + (K DR ) current (19) .
The mechanism by which Rho-kinase suppresses the K DR current remains unclear. One possibility is that Rho-kinase may directly phosphorylate K V channels underlying the K DR current to reduce open probability. Currently, however, there is no experimental evidence in support of such a mechanism. Alternatively, Rho-kinase may indirectly mediate K DR channel suppression by targeting the actin cytoskeleton. A number of vascular studies have implicated Rho-kinase in remodeling of the actin cytoskeleton, where it facilitates the polymerization of actin structures (1; 5; 33) .
Examination of the signaling events underlying this process has revealed that Rhokinase likely phosphorylates and activates LIM-kinase, an endogenous inhibitor of cofilin, a protein that catalyzes the disassembly of filamentous actin (12) . Intriguingly, past studies have demonstrated that both Kv1.2 and Kv1.5, key pore forming subunits of the cerebral arterial K DR current, can couple to actin via the cytoskeletal-binding proteins cortactin and α-actinin2, respectively (11; 21) . In consideration of these observations, it 4 is conceivable that Rho-kinase may regulate K DR current by modifying cytoskeletal elements to influence channel activity, thereby producing the electrical and vasomotor responses associated with the constriction of cerebral arteries.
In this study, we examined the roles of Rho signaling and the actin cytoskeleton in enabling vasoconstrictors to suppress the K DR current and elicit arterial depolarization.
Electrophysiological measurements confirmed that the K DR current was potently inhibited by UTP through a mechanism dependent on Rho-kinase. We found that Rho-kinase facilitated actin polymerization in response to UTP, and that a functional actin cytoskeleton was necessary for K DR current suppression. Furthermore, disrupting the actin cytoskeleton limited the ability of UTP to depolarize and constrict cerebral arteries, similar to the effects of Rho-kinase inhibition. Our findings suggest that Rho-kinase likely modifies actin cytoskeletal structure to reduce K DR channel activity, thereby facilitating the depolarization and constriction of cerebral arteries. Tissue samples were subsequently incubated for 15 minutes in the same medium supplemented with 0.5 mg/ml papain and 1.5 mg/ml dithioerythritol, followed by a 10 minute incubation in medium containing 100 µM Ca
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, 0.7 mg/ml type F collagenase, and 0.4 mg/ml type H collagenase. The tissue was then washed repeatedly in ice-cold isolation medium and triturated with a fire-polished pipette to disperse smooth muscle cells. Cell samples were stored in cold isolation medium for electrophysiological study the same day.
Electrophysiology. Conventional patch clamp electrophysiology was used to measure K DR currents as previously described (20 G-actin was additionally quantified with respect to SM22. Actin blots were re-probed using goat anti-SM22 antibody and HRP-conjugated anti-goat secondary antibody.
SM22 was subsequently visualized, quantified, and used to standardize G-actin content (ie. G-actin/SM22). inhibited the K DR current by 37.0% as measured at +40 mV. This suppression was not associated with changes in whole cell capacitance nor was it attributable to current rundown over time (19) . To emphasize that modulation occurs through a Rho-kinase pathway, we measured the effect of UTP following Rho-kinase inhibition ( Figure 2 ).
Chemicals, drugs and enzymes. H-
Representative recordings in Figure Figure 3A , summary data). Although Rho-kinase inhibition had no significant effect on its own, pre-treatment of vessels with 3 x 10 -6 M H-1152 prevented UTP-induced polymerization. Although these findings suggest that Rho-kinase is key to the formation of actin filaments during smooth muscle contraction, we were concerned by the markedly low percentage of F-actin observed under control conditions. Further examination revealed that a significant amount of F-actin was present in the pellet fraction following the low speed centrifugation step used to remove cellular debris ( Figure 3B ), introducing a potential source of error. To more accurately determine changes in actin, we therefore standardized G-actin to SM22, a stable protein also found within the cytosolic fraction. As shown in Figure 3C , normalized G-actin content was significantly reduced following stimulation of vessels with UTP. In contrast, this effect was not observed when arteries were pre-treated with H-1152, verifying that Rho-kinase is essential to the actin dynamics associated with agonist stimulation.
We subsequently monitored the effect of UTP on K DR current following actin 
DISCUSSION
In this study, we further define the mechanisms by which pyrimidine nucleotides elicit constriction of cerebral arteries to effectively reduce blood flow.
Electrophysiological examination of smooth muscle cells isolated from cerebral arteries revealed a K DR current that was potently inhibited by UTP through a signaling mechanism involving Rho-kinase. On the basis of previous reports, we questioned whether suppression of the K DR current was dependent on the actin cytoskeleton. We found that Rho-kinase activity was requisite for UTP-induced actin polymerization in cerebral arteries and that interfering with actin dynamics prevented Rho-kinase from regulating the K DR current. The initiation of Rho-kinase-mediated alterations in the cytoskeleton and subsequent inhibition of the K DR current appears to be central in enabling agonists such as UTP to depolarize and constrict cerebral arteries.
K DR current and Rho-kinase regulation. Pyrimidine nucleotides, such as UTP, are endogenous signaling compounds secreted by a number of cell types found in the blood and within the arterial wall (18) . When released in close proximity to vascular smooth muscle, pyrimidine nucleotides bind to the P2Y class of receptors to initiate a sustained constriction (7; 15). Cerebral arteries express P2Y2, P2Y4, and P2Y6 receptor subtypes and we have previously investigated the mechanisms enabling UTP to constrict these vessels (19) . Detailed examination revealed that smooth muscle depolarization and subsequent voltage-gated Ca 2+ entry contributed substantially to constriction. We further determined that depolarization was facilitated by the inhibition of an outward K + conductance, the K DR current. Consistent with the view that P2Y receptors can couple to G 12/13 trimeric G proteins to initiate Rho signaling (26), Rho-kinase activity was found to be essential to the suppression of K DR current and to the associated depolarization and constriction.
In the present study we have verified that UTP elicits K DR current inhibition via Rho-kinase. Using conventional whole-cell patch clamp electrophysiology, we readily (12). Conversely, actin polymerization can also be achieved through a reduced rate of disassembly at the pointed (-) end of actin filaments and this is thought to occur upon activation of the Rho-kinase/LIMkinase/cofilin pathway (12) . We assayed the state of actin and found that Rho-kinase indeed facilitates polymerization in intact cerebral arteries stimulated with UTP.
Following stimulation, the percentage of filamentous actin increased and separate analyses of the G-actin content revealed a corresponding decrease. These effects were not observed when arteries were pre-incubated with a Rho-kinase inhibitor prior to agonist application. It may be predicted that such alterations in actin structure would not 13 only impact smooth muscle cell morphology and force generation, but would likely influence the localization and/or regulation of membrane proteins and signaling complexes, including ion channels. Intriguingly, several K V channel subtypes thought to contribute to the K DR current, namely Kv1.2 and Kv1.5, have been shown to be capable of associating with actin through cytoskeleton-binding proteins (11; 21) .
In the present study, pharmacological disruption of actin with either cytochalasin D or latrunculin A effectively abolished the ability of UTP to suppress K DR current.
Therefore, an intact actin cytoskeleton appears essential to Rho-kinase inhibition of the current. Since Rho-kinase promotes actin polymerization, it is likely that alterations in actin structure are associated with changes in cytoskeleton-channel interactions that reduce channel activity. The exact nature of these interactions, and the possible involvement of intermediary proteins, has yet to be resolved. Suppression of the K DR current could also involve channel internalization rather than changes in channel gating.
Several reports have indicated that vascular K DR channels may undergo translocation from the membrane to the cytosol in response to agonists (4; 13). The translocation of K DR channels would reduce current density and facilitate arterial depolarization..
Rho-kinase-mediated depolarization and constriction.
The functional impact of the preceding mechanism was evident in arterial constrictions to UTP, which displayed a dependence on both Rho-kinase activity and the actin cytoskeleton. Treatment of intact cerebral arteries with H-1152 dilated arteries in a concentration-dependent manner.
However, given that Rho-kinase inhibition limits actin polymerization in smooth muscle, part of this dilation is likely due to the disruption of force-generating structures. We therefore directly measured smooth muscle E m to assess changes in ion channel activity in the absence of effects linked to the force generation. These measurements indicated that Rho-kinase inhibition indeed attenuated UTP-induced depolarization, consistent with an increase in outward conductance that would accompany the relief of K DR current suppression. It should be noted that a significant constriction (~50%) remained following Rho-kinase inhibition, indicating that at least one additional signaling pathway is initiated during constriction to pyrimidine nucleotides. This is not surprising given that UTP is known to elicit Ca 2+ waves (14) , events which have not shown a dependence on Rho signaling.
Similar to the effects of Rho-kinase inhibition, actin disruption using cytochalasin Physiological implications. Our findings indicate that Rho-kinase likely suppresses the K DR current by eliciting reorganization of the cortical actin cytoskeleton. We propose that such a mechanism enables UTP to depolarize smooth muscle, thereby facilitating voltage-gated Ca 2+ entry and the constriction of cerebral arteries. We have previously hypothesized that pyrimidine nucleotides activate Rho-kinase through the sequential activation of P2Y receptors, G 12/13 , p115 RhoGEF, and RhoA (19) . Therefore, cytoskeletal remodeling and K DR current suppression are likely to similarly facilitate depolarization and constriction to uridine diphosphate (19) . Furthermore, this type of regulation may not be specific to P2Y receptor agonists as constriction of cerebral arteries to the thromboxane mimetic U46619 also involves Rho-kinase-dependent depolarization (19) . Moreover, U46619 elicits a significant suppression of the K DR current (32), conceivably involving a mechanism analogous to UTP inhibition. A role for Rho-kinase in the voltage-dependent constriction of mesenteric arteries has also been reported (8) , suggesting the capacity of Rho-kinase to regulate electromechanical coupling extends beyond the cerebral circulation. More detailed examination is required to determine whether the modulation of ion channels and E m in these tissues is similarly dependent on cytoskeletal remodeling. Voltage protocol as in Figure 1 . B: net I-V relationship in the presence of H-1152 ± UTP
and following the addition of 4-AP (n = 6). * denotes statistical difference from control. 
